A detailed history of Rogco, LP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Rogco, LP holds 8,068 shares of MRK stock, worth $816,239. This represents 0.36% of its overall portfolio holdings.

Number of Shares
8,068
Previous 8,738 7.67%
Holding current value
$816,239
Previous $1.08 Billion 15.3%
% of portfolio
0.36%
Previous 0.44%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$111.15 - $128.97 $74,470 - $86,409
-670 Reduced 7.67%
8,068 $916 Million
Q2 2024

Aug 14, 2024

SELL
$123.8 - $132.96 $8,170 - $8,775
-66 Reduced 0.75%
8,738 $1.08 Billion
Q1 2024

May 08, 2024

BUY
$113.24 - $131.95 $74,964 - $87,350
662 Added 8.13%
8,804 $1.16 Billion
Q4 2023

Feb 06, 2024

BUY
$100.18 - $109.02 $373,671 - $406,644
3,730 Added 84.54%
8,142 $888 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $454,215 - $504,423
4,412 New
4,412 $454 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $256B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Rogco, LP Portfolio

Follow Rogco, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rogco, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rogco, LP with notifications on news.